Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.

Theranostics · 2021 · PMC8058713 · PMID 33897897

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

extremely significantP <0.01actually significant

P <0.001 was considered as extremely significant difference, P <0.01 as significant difference, and P <0.05 as statistical difference.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.